Value proposition

Accelerating research & development

Integrated BioTherapeutics LLC (IBT Bioservices) is a contract research organization (CRO) offering in vitro and in vivo services as well as products to support your biomedical research and development needs. Whether you are a biotech startup or an established pharmaceutical company, IBT serves as your trusted partner, simplifying the development process and accelerating your journey toward bringing innovative biotherapeutics to patients in need. The team of highly skilled scientists, researchers, and industry experts at IBT work collaboratively to deliver exceptional results and accelerate the development process for its clients. By offering comprehensive services and concierge-level support tailored to each client’s unique project, IBT has distinguished itself as a one-stop shop CRO for virtual biotech companies, research institutions, and pharma companies of all sizes.

IBT Bioservices offers in vitro services including off-the-shelf assays such as antiviral assays, antibacterial assays, ligand binding assays, multiplex assays (ELISA/ Luminex) and immunoassays. In vivo services include over 15+ efficacy models against viral and bacterial infections, immunogenicity models, breeding, and other vivarium services. Visit the IBT Bioservices storefront online to view the full inventory of reagents available for purchase, including a variety of recombinant proteins, antibodies, virus-like particles, pseudoviruses, ELISA kits, and reporter cell lines, all of which can be shipped internationally. All services include custom assay, disease model, and reagent development/production capabilities to cater to each client’s unique project.

Contact us at services@ibtbioservices.com for more information or visit our website at www.IBTBioServices.com.You can find more information on our offerings at www.ibtbioservices.com.

Antiviral small molecule screening using in vitro and in vivo methods, Infectious disease model development, Vaccine immunogenicity and efficacy studies, Cytokine and biomarker analysis, in vivo efficacy testing, antibacterial candidate screening, MIC/MBC, AG129, BALB/c, infection, Influenza, Dengue, CRO, Rockville, NIH, Pharmaceutical, pre-clinical, small molecule, animal models, and flow cytometry